Skip to content

Sable Offshore Corp. SOC Common stock issuance for private placement

Common stock issuance for private placement at other companies

Eton Pharmaceuticals, Inc. logo
Eton Pharmaceuticals, Inc.ETON
$0-100%
Vor Biopharma logo
Vor BiopharmaVOR
$75M
CleanSpark logo
CleanSparkCLSK
$0-100%
Archer Aviation logo
Archer AviationACHR
$0-100%
Unusual Machines logo
Unusual MachinesUMAC
$0-100%
Quantum Computing Inc. logo
Quantum Computing Inc.QUBT
$3.2M-86.4%

Other financials

Income statement

See full
Revenue$1.3M
Operating income-$118.8M-98.6%
Net income-$197.0M-79.9%
EPS (diluted)-$1.37-5.4%

Balance sheet

See full
Cash & equivalents$52.2M-76.8%
Total debt$956.3M+11.9%
Total equity$421.9M+50.3%
Total assets$1.7B+10.7%

Cash flow

See full
Operating cash flow-$82.2M-71.5%
CapEx$21.1M-66.7%
Free cash flow-$103.3M+7.2%

Valuation

See full
Market cap$1.22B-44.4%
Enterprise value$2.13B-24.9%
P/S963.1×

Profitability

See full
Operating margin-36,761.7%
Net margin-39,153.7%
FCF margin-59,902.5%

Returns & leverage

See full
Return on equity-141.7%
Debt / equity2.3×-0.8×
Current ratio0.1×-1.6×

Where this comes from

Reported directly by Sable Offshore Corp. in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfPrivatePlacement.

The official record: Sable Offshore Corp.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sable Offshore Corp.'s common stock issuance for private placement.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Sable Offshore Corp.'s common stock issuance for private placement?
Sable Offshore Corp. (SOC) reported common stock issuance for private placement of $72.39M in Q1 2026.
What does common stock issuance for private placement mean?
Represents the cash proceeds generated from the sale of equity securities directly to private investors rather than through a public offering. This serves as a primary mechanism for raising growth capital while minimizing the regulatory burden and costs associated with public market issuance.